Search - tctmd.com

Displaying 201 - 218 of 218

Sort: Relevancy | Date

Presentation TCT 2013

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Presenter: Patrick Serruys

October 27, 2013

Presentation TCT 2013

Latest Results from ABSORB Extend: Comparison with Xience

Presenter: Bernard Chevalier

October 27, 2013

Presentation TCT 2013

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Presenter: Peter Smits

October 27, 2013

Presentation TCT 2013

Is ABSORB a Workhorse DES? Real-world Perspectives II

Presenter: Robert-Jan van Geuns

October 27, 2013

Presentation TCT 2013

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Presenter: Gregg Stone

October 27, 2013

Presentation

Three-Year Clinical and Multimodality Imaging Results of the ABSORB Trial

Presenter: 53632|Koen Nieman

August 07, 2013

Presentation

ABSORB: Multislice CTA for Noninvasive Assessment of the 18-Month Performance of a Novel Bioresorbable Vascular Scaffolding Device

Presenter: 53632|Koen Nieman

August 07, 2013

Presentation

BIOSOLVE-1: Safety and Performance of Drug-Eluting Absorbable Metal Scaffold (DREAMS) in Patients with De Novo Coronary Lesions

Presenter: Michael Haude

March 18, 2013

Presentation ICI 2012

Absorb Clinical Data

Presenter: B. Chevalier

December 03, 2012

Presentation TCT 2012

TCT-40. Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND...

Presenter: Takashi Muramatsu

October 23, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

ABSORB III and IV (Abbott Vascular) Pivotal Clinical Trial Program

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCTAP 2012

From ABSORB Cohort A to ABSORB III and IV Randomized Trials

Presenter: Stephen G. Ellis

April 26, 2012

Presentation TCT 2012

Quantitative OCT Analysis of In-stent Neointimal Growth after Implantation of ABSORB™ BVS in a Diabetic Animal Model.

Presenter: Nienke van Ditzhuijzen, Oana Sorop, Mieke van den Heuvel, Jurgen M.R. Ligthart, Karen T. Witberg, Richard van Duin, Ilona Krabbendam-Peters, Douglas Follett, Nagarajan Ramesh, Richard Rapoza, Dirk J. Duncker, Evelyn Regar, Heleen M.M. van Beusekom, Hector M. Garcia-Garcia, Wim J. van der Giessen

January 03, 2012

Presentation TCT 2012

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Presenter: John Ormiston, William Wijns, Charlene Knape, Mathias Vrolix, James Stewart, Mark Webster, Robert Whitbourn, Alexandra Lansky, Hiram Bezzera, Peter Fitzgerald, David Kandzari

January 03, 2012

Advertisement

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Latest Results from ABSORB Extend: Comparison with Xience

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Is ABSORB a Workhorse DES? Real-world Perspectives II

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Three-Year Clinical and Multimodality Imaging Results of the ABSORB Trial

ABSORB: Multislice CTA for Noninvasive Assessment of the 18-Month Performance of a Novel Bioresorbable Vascular Scaffolding Device

BIOSOLVE-1: Safety and Performance of Drug-Eluting Absorbable Metal Scaffold (DREAMS) in Patients with De Novo Coronary Lesions

Absorb Clinical Data

TCT-40. Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND...

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

ABSORB III and IV (Abbott Vascular) Pivotal Clinical Trial Program

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

From ABSORB Cohort A to ABSORB III and IV Randomized Trials

Quantitative OCT Analysis of In-stent Neointimal Growth after Implantation of ABSORB™ BVS in a Diabetic Animal Model.

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content